Addressing a Data Problem to Enable AI-Drug Discovery
Jul 15, 2026 - 41:05
Radio and PodcastLive Radio & PodcastsBusiness
An Off-the-Shelf Cell Therapy to Calm Cytokine Storms
Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to...
About This Episode
An Off-the-Shelf Cell Therapy to Calm Cytokine Storms is an episode from The Bio Report by Levine Media Group. Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. M...
Podcast
This episode belongs to The Bio Report.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 29, 2026, 28:29 long, audio available.
Related Episodes
Continue listening to more episodes from The Bio Report.
Addressing the Treatment Gap in Ischemic Stroke
Jul 1, 2026 - 30:18
A Pipeline in a Product that Reimagines Control of Inflammation
Jun 24, 2026 - 24:04
Building a Genetics Engine to Crack the Target Bottleneck
Jun 17, 2026 - 52:43
Stopping Shape-Shifting Tumors with a First-in-Class Epigenetic Drug
Jun 10, 2026 - 28:10
Rewriting the Rules of Antibody Drug Design
Jun 3, 2026 - 37:31
Mapping Cellular Stress Biology to Tackle Undruggable Targets
May 27, 2026 - 30:10